Pharmaceutical Composition for Treating Fatty Liver Disease

Shionogi & Co., Ltd. filed patent application US20260091022A1 (Application No. 19413251) claiming a pharmaceutical composition comprising a compound of Formula (I) for treating and/or preventing fatty liver disease. The claimed compound has R1 as haloalkyl or non-aromatic carbocyclyl, R2 as hydrogen or halogen, R3 as halogen, ring A as -O-(CH2)- or -(CH2)2-, and R4/R5 as alkyl/haloalkyl groups. Inventors include Hideo Yukioka, Atsuyuki Shimazaki, Tadateru Hamada, and Naoki Ohyabu.

Pharmaceutical companies developing fatty liver disease therapeutics should review this publication for potential freedom-to-operate considerations. Patent prosecution typically takes 2-3 years from filing. No immediate compliance action is required, but R&D teams should assess whether this application could affect their pipeline compounds. Third parties may submit prior art references during examination.